Using a single-needle biopsy and new technology for tumor diagnosis, researchers provide a more detailed window into cancer biology, tumor type, and mechanisms of therapy response and resistance
A common prostate cancer mutation retargets an epigenetic complex to force prostate cells down a malignant path, creating a possible therapeutic opportunity in the process.